ATP binding cassette transporters and drug resistance in breast cancer.

F Leonessa, R Clarke - Endocrine-related cancer, 2003 - erc.bioscientifica.com
Resistance to chemotherapy is a critical issue in the management of breast cancer patients.
The nature of clinical drug resistance is likely to be multifactorial. However, in the last …

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

DM Bradshaw, RJ Arceci - Journal of Clinical Oncology, 1998 - ascopubs.org
For cytotoxic agents to have an effect on tumor cells, drugs must first be transported into the
cell, potentially be metabolized to an active form, and interact appropriately with target …

18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma

L Kostakoglu, SJ Goldsmith - Journal of Nuclear Medicine, 2003 - Soc Nuclear Med
PET is a unique form of diagnostic imaging that observes in vivo biologic changes using
radiopharmaceuticals that closely mimic endogenous molecules. 18F-FDG, which allows the …

The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis

R Taillefer - Seminars in nuclear medicine, 1999 - Elsevier
The wide availability and the extensive use of screening mammography have resulted in an
earlier diagnosis of breast cancer and in a significant reduction in the relative risk of dying …

Molecular imaging of gene expression and protein function in vivo with PET and SPECT

V Sharma, GD Luker… - Journal of Magnetic …, 2002 - Wiley Online Library
Molecular imaging is broadly defined as the characterization and measurement of biological
processes in living animals, model systems, and humans at the cellular and molecular level …

Visualization of multidrug resistance in vivo

NH Hendrikse, EJF Franssen… - European journal of …, 1999 - Springer
Various mechanisms are involved in multidrug resistance (MDR) for chemotherapeutic
drugs, such as the drug efflux pumps, P-glycoprotein (Pgp) and multidrug resistance …

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX‐710 combined with doxorubicin and vincristine in patients with recurrent small cell …

L Gandhi, MW Harding, M Neubauer… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. Tumors with multidrug resistance (MDR) frequently up‐regulate efflux
proteins, including MDR‐associated protein (MRP‐1) and P‐glycoprotein (Pgp). MDR …

99mTc-MIBI in the evaluation of breast cancer biology

S Del Vecchio, M Salvatore - European journal of nuclear medicine and …, 2004 - Springer
A major area of interest in nuclear medicine is the scintigraphic in vivo evaluation of complex
cellular processes involved in tumour growth, progression and response to treatment with …

Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin

RA Peck, J Hewett, MW Harding, YM Wang… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: To evaluate the safety, tolerability, and pharmacokinetics of biricodar (VX-710),
an inhibitor of P-glycoprotein (P-gp) and multidrug resistance–associated protein (MRP1) …

Single-photon agents for tumor imaging:201TI,99mTc-MIBI, and99mTc-tetrofosmin

M Fukumoto - Annals of nuclear medicine, 2004 - Springer
This review aims at fostering comprehension and knowledge not only for expert physicians
who can skillfully handle various techniques for tumor imaging but also for young …